Health & Fitness

JAMA Oncology Author Interviews

by JAMA Network

Claiming needs an RSS feed. Contact us.

Listen on Apple Podcasts

Recently ranked · United States

Last recorded placements from this show’s chart history. These are not current rankings.

Not on the United States charts we track today.

If you like JAMA Oncology Author Interviews, try…

JAMA Dermatology Author Interviews

From JAMA Network

JAMA Clinical Reviews

From JAMA Network

Breast Cancer Trials

Latest episodes

Metastatic Recurrence Among Adolescents and Young Adults With Cancer

November 26, 2025 · 12 min

Interview with Ann Brunson, MS, and Theresa H. M. Keegan, PhD, MS, authors of Metastatic Recurrence Among Adolescents and Young Adults With Cancer. Hosted by Vivek Subbiah, MD. Related Content: Metastatic Recurrence Among Adolescents…
Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality

October 30, 2025 · 12 min

Interview with Yiwen Zhang, PhD, and Edward L. Giovannucci, MD, ScD, authors of Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality. Hosted by Vivek Subbiah, MD. Related Content…
Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer

September 18, 2025 · 13 min

Interview with Jiyoung Ahn, PhD, author of Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer. Hosted by Vivek Subbiah, MD. Related Content: Oral Bacterial and Fungal Microbiome and Subsequent Risk for…
Proportional Sedation for Persistent Agitated Delirium in Palliative Care

July 31, 2025 · 18 min

Interview with David Hui, MD, and Eduardo Bruera, MD, authors of Proportional Sedation for Persistent Agitated Delirium in Palliative Care: A Randomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Proportional…
New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance

May 29, 2025 · 19 min

Interview with Thorir Einarsson Long, MD, PhD, and Ola Landgren, MD, PhD, authors of New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. Hosted by Vivek Subbiah, MD. Related Content: New Definition of…

Show 7 more episodesShow fewer episodes

Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury

April 24, 2025 · 12 min

Interview with Shruti Gupta, MD, MPH, author of Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury. Hosted by Vivek Subbiah, MD. Related Content: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury
Accelerated Aging in Survivors of Childhood Cancer

March 20, 2025 · 19 min

Interview with Jennifer M. Yeh, PhD, and Lisa R. Diller, MD, authors of Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions. Hosted by Vivek Subbiah, MD. Related Content: Accelerated…
Academic-Community Partnership and Deaths in Promyelocytic Leukemia

February 27, 2025 · 19 min

Interview with Anand P. Jillella, MD, author of Academic-Community Partnership and Deaths in Promyelocytic Leukemia: The Nonrandomized ECOG-ACRIN EA9131 Trial. Hosted by Vivek Subbiah, MD. Related Content: Academic Community…
Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

January 30, 2025 · 12 min

Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD. Related Content: Intracranial Outcomes…
Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020

December 5, 2024 · 16 min

Interview with Katrina A. B. Goddard, PhD, author of Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020. Hosted by Vivek Subbiah, MD. Related Content: Estimation of Cancer Deaths Averted…
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib

November 21, 2024 · 19 min

Interview with Hagop Kantarjian, MD, author of Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content…
Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

October 24, 2024 · 21 min

Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Anti–Programmed Death…

Full episode archive on Apple Podcasts →

About the show

Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.